Bleakley Financial Group’s Vaxart VXRT Stock Holding History

Bleakley Financial Group’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-13,788	Closed	-$13.2K	–	954
2022 Q4	$13.2K	Buy	+13,788	New	+$19.5K	﹤0.01%	865

Other funds holding VXRT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bleakley Financial Group's VXRT Position: Q1 2023 in Review

Bleakley Financial Group sold out of Vaxart (VXRT) in Q1 2023, closing a stake of 13,788 shares — an estimated $13.2K sold.

Bleakley Financial Group first reported a position in VXRT in Q4 2022 and held it in 1 quarter. The position peaked at $13.2K in Q4 2022. 109 funds tracked by Wall St. Rank hold VXRT as of Q1 2023.

Bleakley Financial Group reported no remaining Vaxart position as of Q1 2023 after selling out during the quarter.
Bleakley Financial Group sold 13,788 Vaxart shares in Q1 2023, an estimated $13.2K.
Bleakley Financial Group first reported a position in Vaxart in Q4 2022 and held it in 1 quarter.
Bleakley Financial Group's Vaxart position peaked at $13.2K in Q4 2022.
109 funds tracked by Wall St. Rank held Vaxart as of Q1 2023.

Based on Bleakley Financial Group's 13F filing for Q1 2023, filed 12 May 2023.